Tagra Biotechnologies (stand 934) focuses on the development and manufacturing of microencapsulated ingredients such as vitamins, oils, sunscreen agents, pigments and more.

Tagra is the first company to patent a unique innovative Release on Demand (RND) Microencapsulation Technology. Tagra’s platform addresses industry challenges of stability, efficiency, and compatibility with other ingredients in cosmetic formulations. The technology enables masking, protection, and releases of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagra’s microcapsules are friction released through consumer application.

Tagra launched this year DeeperCaps: encapsulated pigments dedicated to dark skin tones. Thanks to the sophisticated double-layer microcapsule structure, when the capsules are broken the pigments adhere effortlessly to skin and give great coverage, with a natural perfect color-match, but without white-cast effect.

They offer:
• Perfect skin tone color-match & coverage
• Multiple applications
• Reliable & sustainable ingredient

More info: Tagra Biotechnologies, Tel: +972 4 69 03 470; Email: [email protected]; Website: www.tagra.com